Dr. Jorge Plutzky, MD

Dr. Plutzky practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Plutzky's NPI, 1639135023, was assigned on April 25, 2006. Dr. Plutzky graduated from University of North Carolina at Chapel Hill School of Medicine in 1986. Dr. Plutzky holds Massachusetts license 71170.

Dr. Plutzky's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Plutzky's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Plutzky is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Plutzky to 3 more hospitals and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Plutzky practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Plutzky's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Plutzky is licensed in Massachusetts.

CMS data shows 240 Medicare services from Dr. Plutzky across 6 procedure codes in 2024, for 147 Medicare patients. Medicare paid $15,146 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 147 Medicare patients who saw Dr. Plutzky in 2024. The largest group is 75 to 84, with 60 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Plutzky's median patient age at 70, with 49% women.

In 2024, Dr. Plutzky wrote 800 Medicare Part D claims for 133 patients. 73% of them were for generic drugs. CMS names the drug for 664 of them, across 14 drugs with 11 or more claims each, at $207,117 in total drug cost. In 2023, CMS named 607 claims across 15 drugs.

Dr. Plutzky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Plutzky as offering telehealth.

Dmand AI links 113 papers to Dr. Plutzky, published from 2010 to 2025. 2024 was the busiest year, with 16. The most frequent topics are Cardiovascular Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors and Obesity. Dr. Plutzky has published most often in Circulation. Dr. Plutzky's most frequent co-authors are Jonathan D. Brown, MD, Benjamin Morgan Scirica, MD and Alexander Turchin, MD.

Dmand AI links Dr. Plutzky to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Hyperglycemia, Hyperlipoproteinemia Type V and Diabetes Mellitus, Type 2. Open Payments lists research payments to Dr. Plutzky that name 1 trial.

CMS Open Payments shows 507 general payments to Dr. Plutzky from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. VIVUS, Inc. paid the most, $328,062. It also lists 32 research payments totaling $66,870 from 2016 to 2024, naming 1 clinical trial.

Dr. Plutzky graduated from University of North Carolina at Chapel Hill School of Medicine in 1986.